Liquid Biopsy in Bladder Cancer
Author:
Cui Yan,Cao Muyang
Reference41 articles.
1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394–424
2. Humphrey PA, Moch H, Cubilla AL, Ulbright TM, Reuter VE (2016) The 2016 WHO classification of tumours of the urinary system and male genital organs-part B: prostate and bladder tumours. Eur Urol 70:106–119
3. Necchi A, Madison R, Pal SK et al (2020) Comprehensive genomic profiling of upper-tract and bladder urothelial carcinoma. Eur Urol Focus 7(6):1339–1346
4. Lopez-Beltran A, Cheng L, Gevaert T et al (2020) Current and emerging bladder cancer biomarkers with an emphasis on urine biomarkers. Expert Rev Mol Diagn 20:231–243
5. Cheng F, Su L, Qian C (2016) Circulating tumor DNA: a promising biomarker in the liquid biopsy of cancer. Oncotarget 7:48832–48841